Log on / register
Feedback | Support | My details
Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells.
Camirand A, Zakikhani M, Young F, Pollak M
Breast Cancer Res 2005, 7:R570-9
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors
Inbar-Rozensal D, Castiel A, Visochek L, Castel D, Dantzer F, Izraeli S, Cohen-Armon M
Breast Cancer Research 2009, 11:R78 (9 November 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
2.


Research article    
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
Lisztwan J, Pornon A, Chen B, Chen S, Evans DB
Breast Cancer Research 2008, 10:R56 (8 July 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.